
ELIXINOL GLOBAL
Share · AU000000EXL4 · A2JB8D (XASX)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of ELIXINOL GLOBAL
No Price
28.04.2026 20:00
Current Prices from ELIXINOL GLOBAL
| Exchange | Ticker | Currency | Last Trade | Price | Daily Change |
|---|---|---|---|---|---|
UTC |
ELLXF
|
USD
|
28.04.2026 20:00
|
0,007 USD
| 0,00 USD |
Company Profile for ELIXINOL GLOBAL Share
Elixinol Wellness Limited, through its subsidiaries, manufactures and distributes hemp derived nutraceuticals, cosmetics, and food products under the Elixinol and Hemp Foods Australia brands in the Americas, Europe, and Australia. It offers hemp derived cannabidiol and food products, dietary supplements, topicals, and skincare products. The company was formerly known as Elixinol Global Limited and changed its name to Elixinol Wellness Limited in May 2021. The company was incorporated in 2017 and is headquartered in Sydney, Australia.
Company Data
Name ELIXINOL GLOBAL
Company Elixinol Wellness Limited
Website
https://www.elixinolwellness.com
Primary Exchange
ASX
WKN A2JB8D
ISIN AU000000EXL4
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Natalie Butler
Country Australia
Currency EUR
Employees -
Address 680 George Street, 2000 Sydney
IPO Date 2018-06-05
Stock Splits
| Date | Split |
|---|---|
| 02.12.2024 | 1:8 |
| 06.05.2020 | 579:500 |
Ticker Symbols
| Name | Symbol |
|---|---|
| Over The Counter | ELLXF |
| Frankfurt | E8M.F |
More Shares
Investors who hold ELIXINOL GLOBAL also have the following shares in their portfolio:
